103 indexable Biopharma Outsourcing companies headquartered in Japan, ranked by total equity funding and recent funding momentum. Combined disclosed equity funding of $61.9M across 14 funded companies.
| # | Company | Funding | Valuation | Stage | Latest round | Employees | Founded | Momentum |
|---|---|---|---|---|---|---|---|---|
| 1 |
FerroptoCure
Provider of ferroptosis drug discovery and development solutions |
$3.1M | — | Series A | Series A Sep 2025 | — | 2022 | ↑ Active |
| 2 |
xCARE
Provider of pharmaceuticals development & commercialization services |
$871.2K | — | Seed | Seed Jan 2026 | 7 | 2022 | ↑ Active |
| 3 |
Proteobridge
CRO offering drug development and research services for protein array manufacturing |
$1.6M | — | Seed | Seed Sep 2025 | 12 | 2018 | ↑ Active |
| 4 |
Bacchus Bio innovation
CDMO focused on manufacturing of microorganism based drugs |
$11.3M | — | Series A | Series A Nov 2024 | 22 | 2020 | ↑ Active |
| 5 |
Toregem Biopharma
Bio firm offering research and development in dental drug development |
$10.4M | — | Series B | Series B Aug 2024 | 5 | 2020 | ↑ Active |
| 6 |
RevolKa
Provider of AI development services for biopharma sector |
$1.7M | — | Series A | Series A May 2025 | 23 | 2021 | ↑ Active |
| 7 |
LiberoThera
Provides drug discovery using cell-free membrane protein preparation and unnatural amino acid |
$7.5M | — | Series A | Series A Aug 2024 | 10 | 2018 | ↑ Active |
| 8 |
Quastella
Provider of cell quality control and manufacturing services |
$752.1K | — | Seed | Conventional Debt Jul 2025 | — | 2019 | ↑ Active |
| 9 |
DLeader
Developer of an AI platform streamlining drug discovery and development |
$120K | — | Seed | Seed Aug 2025 | — | 2024 | ↑ Active |
| 10 |
HOIST
Provider of drugs development services |
$5.4M | — | Seed | Seed Apr 2023 | 4 | 2019 | — |
| 11 |
Knowledge Palette
Provider of research, development, and manufacturing services for small molecule drugs |
$4.6M | — | Series A | Series A Jul 2023 | 4 | 2018 | — |
| 12 |
Sanamedi
Provider of pharmaceutical quality assurance consulting services |
$10M | — | Series B | Series B Feb 2016 | — | 2012 | — |
| 13 |
Cellshoot Therapeutics
Provider of drug research & development services for bio pharma industry |
$1.7M | — | Seed | Seed Aug 2022 | — | 2021 | — |
| 14 |
Curreio
CRO focused on drug discovery based on structural analysis using a cryo-electron microscope |
$2.8M | — | Series A | Series A Jun 2021 | 7 | 2019 | — |
| 15 |
neumo
Provider of diversified consulting services for biopharma sector |
— | — | Series A | Series A Apr 2026 | — | 2017 | ↑ Active |
| 16 |
iPS Portal
Biotechnology company that specializes in iPS cell technology |
— | — | Seed | Seed Mar 2026 | 20 | 2014 | ↑ Active |
| 17 |
ARCALIS
Provider of drug discovery support and CDMO services for mRNA therapeutics and vaccines |
— | — | Seed | Seed Nov 2024 | — | 2021 | ↑ Active |
| 18 |
Save Medical
Provider of software & clinical development, regulatory compliance, and commercialization services for biopharma sector |
— | — | Seed | Seed Jul 2024 | 7 | 2018 | ↑ Active |
| 19 |
Yap
Provider of pharmaceutical supply chain solutions |
— | — | Seed | Seed Feb 2024 | 2 | 2023 | — |
| 20 |
ReqMed
Provider of drug development, consulting, and venture funding services |
— | — | Funding Raised | Unattributed Sep 2023 | 18 | 1998 | — |
| 21 |
Kinopharma
Specialty company engaged in research and development for treatment of various diseases |
— | — | Seed | Seed Jul 2023 | — | 2005 | — |
| 22 |
UNOMI
Offers contract research and development of nutritional supplements |
— | — | Seed | Seed Jun 2021 | — | 2020 | — |
| 23 |
iBody
Provider of a monoclonal antibody excavation technology |
— | — | Seed | Seed Aug 2020 | — | 2018 | — |
| 24 |
Takeda
Large diversified pharma company |
— | — | Public | Conventional Debt Nov 2018 | 6,638 | 1781 | — |
| 25 |
Epigeneron
Drug discovery service provider for epigenetic drugs and anti-microbial drugs |
— | — | Deadpooled | Seed Mar 2018 | 5 | 2015 | — |
| 26 |
ClinCloud
Company offering data management and pharmacovigilance services for clinical trials |
— | — | Seed | Seed Dec 2015 | — | 2014 | — |
| 27 |
Asahi Kasei
CDMO focused on manufacturing of liquid, solid & injectable drug formulations |
— | — | Public | Grant (prize money) 2015 | — | 1931 | — |
| 28 |
3h clinical trial
3H Clinical Trial offers health event planning, management IT solutions, healthcare marketing research and insurance support services. |
— | — | Acquired | — | 250 | 2005 | — |
| 29 |
A2 Healthcare
Full-service CRO based out of Japan |
— | — | Unfunded | — | 1,155 | 2003 | — |
| 30 |
Alfresa Holdings Corporation
Manufacture, import & export and wholesaling of drugs and other healthcare products |
— | — | Public | — | 10,936 | 2003 | — |
| 31 |
Alfresa Pharma Corporation
Contract manufacturer of solids and liquid dosage forms |
— | — | Unfunded | — | — | 1981 | — |
| 32 |
apoplus station
Apoplus Station provides CSO and CRO business services focusing on medical well being. |
— | — | Acquired | — | 790 | 1993 | — |
| 33 |
ASAJES Ventures
Provider of investment and clinical development for late-stage biopharmaceutical drug candidates |
— | — | Unfunded | — | — | 2018 | — |
| 34 |
Ascent Development Services
Provider of regulatory and consulting services to biopharma sector |
— | — | Unfunded | — | 23 | 2018 | — |
| 35 |
Axcelead Drug Discovery Partners
Provider of drug research & consulting services |
— | — | Funding Raised | — | 70 | 2017 | — |
| 36 |
Bushu Pharma
Provider of quality assurance services |
— | — | Acquired | — | 930 | 2014 | — |
| 37 |
Cancer Precision Medicine
Provider of gene and immune analysis services for precision medicine |
— | — | Unfunded | — | — | 2017 | — |
| 38 |
CELLIAN-BiCLO
Manufacturer of cell and gene therapy products |
— | — | Funding Raised | — | — | 2022 | — |
| 39 |
CellSource
Provider of biopharma business consulting services |
— | — | Public | — | 138 | 2015 | — |
| 40 |
Chugai Pharmaceutical
Developer of innovative pharmaceutical products and services |
— | — | Acquired | — | 15 | 1925 | — |
| 41 |
CMIC HOLDINGS
Contract service provider for biopharma companies |
— | — | Acquired | — | — | 1985 | — |
| 42 | CMIC Holdings Company | — | — | Public | — | 7,646 | 1992 | — |
| 43 |
Cognano
Manufactures proteins and antibodies |
— | — | Deadpooled | — | — | 2015 | — |
| 44 |
Cosmo Bio
Provider of drug research and sales & marketing services for life science companies |
— | — | Public | — | — | 1983 | — |
| 45 |
Daito Pharmaceuticals
CMO of APIs, intermediates and formulations |
— | — | Public | — | 1,060 | 1942 | — |
| 46 |
dot world
DOT World is a pharmaceutical company that provides clinical studies for new drugs and medical devices, data management and biostatistics. |
— | — | Acquired | — | 11 | 2006 | — |
| 47 |
E-Trial
EPS group company specializing in the conduct and coordination of EDC-based trials |
— | — | Deadpooled | — | — | 2006 | — |
| 48 | Ep-Force | — | — | Acquired | — | 400 | 2019 | — |
| 49 |
EP-Sogo
SMO offering its services for the conduct of clinical trials |
— | — | Funding Raised | — | 737 | 1999 | — |
| 50 |
EPMate
Company offering clinical drug development services |
— | — | Deadpooled | — | — | 2005 | — |
Provider of ferroptosis drug discovery and development solutions. It is a developer of therapeutic drugs to treat cancer and other diseases.
Provider of pharmaceuticals development & commercialization services
Provider of Vivo reactions on protein arrays intended to deliver innovative research approach. The company performs high-precision immune profiling based on the resources and developed technologies established by the national institute of advanced industrial science and technology. enabling researchers to study drug discovery, regenerative medicine, and diagnosis.
CDMO focused on manufacturing of microorganism based drugs
Bio firm offering research and development in dental drug development. It provides tooth regeneration medicine, treatment, and dental regenerative therapy.
Provider of AI development services for biopharma sector
Provides drug discovery using cell-free membrane protein preparation and unnatural amino acid
Provider of cell quality control and manufacturing services
Developer of an AI platform streamlining drug discovery and development. The platform integrates machine learning and computational modeling to accelerate therapeutic development. It leverages deep learning and generative models to transform the drug discovery pipeline. The platform supports target identification, molecular design, and preclinical evaluation. It uncovers novel therapeutics with greater speed, precisi
Operator of a medical research and development company intended to discover and develop cancer treatment drugs. The company's research uses technology to provide information and realize the future of innovative cancer therapeutic drugs and healthy longevity, enabling clinicians to treat patients without hassle.
Developer of phenotypic regenerative medicine platforms designed to overcome intractable diseases by manipulating cells with information. The company's platform performs accurate all-gene expression analysis technology to acquire the state of cells treated with various types of drugs and media as large-scale data to extract information, enabling pharmaceutical companies and research institutes to improve the quality
Provider of pharmaceutical quality assurance consulting services
Kyoto University Innovation Capital
Nippon Venture Capital
Tohoku University Venture Partners
ANRI
Beyond Next Ventures
Mitsubishi UFJ Capital
Station AI
D3
Digital Pharma Lab
HILL HOUSE
Healthcare Innovation
JAFCO Group
Rankings are computed by Radar (Fliar BI) from the Radar company master and are updated periodically. Funding and momentum scores use disclosed equity-funding data only. Figures may lag private rounds. Last updated 2026-06-21.
_1584095064231.png){kind=logo}
